Extended Data Fig. 5: Predictive accuracy of CM-DILI PRSgw for Flucloxacillin or Amoxicillin-clavulanate DILI.
From: Polygenic architecture informs potential vulnerability to drug-induced liver injury
Distribution of CM-DILI PRSgw and HC-DILI PRSgw in Flucloxacillin or Amoxicillin-clavulanate DILI patients with the indicated DILI type (cholestasis/mixed or hepatocellular). AUROC (95% CI) and P-value of two-tailed Wilcoxon–Mann–Whitney U test were shown.
